Tolperisone in Acute Muscle Spasm of the Back
Clinical trial NCT03802565 · COMPLETED
Trial details
- NCT number
- NCT03802565
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2019-06-28
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.